Increased inflammation in atherosclerotic lesions of diabetic akita-LDLr -/- mice compared to nondiabetic LDLr -/- mice

Experimental Diabetes Research

Volumn 2012, Issue , 2012, Pages

  Engelbertsen, Daniel ^a   To, Fong ^a   Dunér, Pontus ^a   Kotova, Olga ^a   Söderberg, Ingrid ^a   Alm, Ragnar ^a   Gomez, Maria F ^a   Nilsson, Jan ^a   Bengtsson, Eva ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; COLLAGEN; CXCL2 CHEMOKINE; GELATINASE B; GLUCOSE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; OSTEOPONTIN; TRIACYLGLYCEROL; VASCULAR CELL ADHESION MOLECULE 1; AUTACOID; BIOLOGICAL MARKER;

AKITA MOUSE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BRACHIOCEPHALIC TRUNK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; EXPERIMENTAL MODEL; FEMALE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HEART MUSCLE FIBROSIS; INFLAMMATION; INFLAMMATORY CELL; MACROPHAGE; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE; STRAIN DIFFERENCE; T LYMPHOCYTE; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; AORTA; AORTITIS; BLOOD; CELL CULTURE; COMPARATIVE STUDY; DIABETIC ANGIOPATHY; DISEASE MODEL; GENETICS; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; METABOLISM; MOUSE MUTANT; PATHOLOGY;

ANIMALS; AORTA; AORTITIS; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CELLS, CULTURED; CHOLESTEROL; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; DISEASE MODELS, ANIMAL; FEMALE; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; MALE; MICE; MICE, KNOCKOUT; PLAQUE, ATHEROSCLEROTIC; RECEPTORS, LDL; SEX FACTORS; T-LYMPHOCYTES; TRIGLYCERIDES;

EID: 84871406504     PISSN: 16875214     EISSN: 16875303     Source Type: Journal    
DOI: 10.1155/2012/176162     Document Type: Article

References (54)

1. Laing S. P., Swerdlow A. J., Slater S. D., Burden A. C., Morris A., Waugh N. R., Gatling W., Bingley P. J., Patterson C. C., Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia 2003 46 6 760 765 2-s2.0-0038235851 10.1007/s00125-003-1116-6 (Pubitemid 36831403)
2. Nathan D. M., Cleary P. A., Backlund J. Y. C., Genuth S. M., Lachin J. M., Orchard T. J., Raskin P., Zinman B., Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. New England Journal of Medicine 2005 353 25 2643 2653 2-s2.0-29144453326 10.1056/NEJMoa052187 (Pubitemid 41817713)
3. Ruderman N. B., Haudenschild C., Diabetes as an atherogenic factor. Progress in Cardiovascular Diseases 1984 26 5 373 412 2-s2.0-0021753055 (Pubitemid 14170169)
4. Brownlee M., Biochemistry and molecular cell biology of diabetic complications. Nature 2001 414 6865 813 820 2-s2.0-0035856980 10.1038/414813a (Pubitemid 34000785)
5. Lenzen S., The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia 2008 51 2 216 226 2-s2.0-37549029242 10.1007/s00125-007- 0886-7
6. Bolzán A. D., Bianchi M. S., Genotoxicity of streptozotocin. Mutation Research 2002 512 2-3 121 134 2-s2.0-0036898999 (Pubitemid 35441051)
7. Muller Y. D., Golshayan D., Ehirchiou D., Immunosuppressive effects of streptozotocin-induced diabetes result in absolute lymphopenia and a relative increase of T regulatory cells. Diabetes 2011 60 9 2331 2340 10.2337/db11-0159
8. + T cells. PLoS ONE 2011 6 5 2-s2.0-79956337421 10.1371/journal.pone. 0020214 e20214
9. -/- mice. BMC Immunology 2010 11, article 58 2-s2.0-78649598153 10.1186/1471-2172-11-58
10. Ait-Oufella H., Herbin O., Bouaziz J. D., Binder C. J., Uyttenhove C., Laurans L., Taleb S., Van Vré E., Esposito B., Vilar J., Sirvent J., Van Snick J., Tedgui A., Tedder T. F., Mallat Z., B cell depletion reduces the development of atherosclerosis in mice. Journal of Experimental Medicine 2010 207 8 1579 1587 2-s2.0-77954914191 10.1084/jem.20100155
11. Doran A. C., Lipinski M. J., Oldham S. N., B-cell aortic homing and atheroprotection depend on Id3. Circulation Research 2012 110 1 e1 e12 10.1161/CIRCRESAHA.111.256438
12. Kyaw T., Tay C., Khan A., Dumouchel V., Cao A., To K., Kehry M., Dunn R., Agrotis A., Tipping P., Bobik A., Toh B. H., Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis. Journal of Immunology 2010 185 7 4410 4419 2-s2.0-77958125881 10.4049/jimmunol.1000033
13. Kyaw T., Tay C., Krishnamurthi S., B1a B lymphocytes are atheroprotective by secreting natural IgM that increases IgM deposits and reduces necrotic cores in atherosclerotic lesions. Circulation Research 2011 109 8 830 840 10.1161/CIRCRESAHA.111.248542
14. Ait-Oufella H., Salomon B. L., Potteaux S., Robertson A. K. L., Gourdy P., Zoll J., Merval R., Esposito B., Cohen J. L., Fisson S., Flavell R. A., Hansson G. K., Klatzmann D., Tedgui A., Mallat Z., Natural regulatory T cells control the development of atherosclerosis in mice. Nature Medicine 2006 12 2 178 180 2-s2.0-32244445416 10.1038/nm1343 (Pubitemid 43214743)
15. Wang J., Takeuchi T., Tanaka S., Kubo S. K., Kayo T., Lu D., Takata K., Koizumi A., Izumi T., A mutation in the insulin 2 gene induces diabetes with severe pancreatic β -cell dysfunction in the Mody mouse. Journal of Clinical Investigation 1999 103 1 27 37 2-s2.0-0032918044 (Pubitemid 29031160)
16. Hsueh W., Abel E. D., Breslow J. L., Recipes for creating animal models of diabetic cardiovascular disease. Circulation Research 2007 100 10 1415 1427 (Pubitemid 46834754)
17. +/Akita: apoe-deficient mice exhibit exaggerated hypercholesterolemia and atherosclerosis. American Journal of Physiology 2011 301 1 E145 E154 2-s2.0-79959607132 10.1152/ajpendo.00034.2011
18. -/- mice show severely elevated lipid levels and increased atherosclerosis: a model of type 1 diabetic macrovascular disease. Journal of Lipid Research 2011 52 8 1483 1493 2-s2.0-79960685038 10.1194/jlr.M014092
19. Hartvigsen K., Chou M. Y., Hansen L. F., Shaw P. X., Tsimikas S., Binder C. J., Witztum J. L., The role of innate immunity in atherogenesis. Journal of Lipid Research 2009 50 S388 S393 2-s2.0-66349096056 10.1194/jlr.R800100-JLR200
20. Tabas I., Williams K. J., Borén J., Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation 2007 116 16 1832 1844 2-s2.0-37349021003 10.1161/CIRCULATIONAHA.106.676890 (Pubitemid 350287108)
21. Basta G., Schmidt A. M., De Caterina R., Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovascular Research 2004 63 4 582 592 2-s2.0-4043058031 10.1016/j.cardiores.2004.05.001 (Pubitemid 39078671)
22. Yan S. F., Ramasamy R., Schmidt A. M., Mechanisms of Disease: advanced glycation end-products and their receptor in inflammation and diabetes complications. Nature Clinical Practice Endocrinology and Metabolism 2008 4 5 285 293 2-s2.0-42449109476 10.1038/ncpendmet0786 (Pubitemid 351571138)
23. Fredrikson G. N., Söderberg I., Lindholm M., Dimayuga P., Chyu K. Y., Shah P. K., Nilsson J., Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences. Arteriosclerosis, Thrombosis, and Vascular Biology 2003 23 5 879 884 2-s2.0-0038639407 10.1161/01.ATV.0000067937. 93716.DB (Pubitemid 36566181)
24. Wigren M., Bengtsson D., Dunér P., Olofsson K., Björkbacka H., Bengtsson E., Fredrikson G. N., Nilsson J., Atheroprotective effects of alum are associated with capture of oxidized LDL antigens and activation of regulatory T cells. Circulation Research 2009 104 12 e62 e70 2-s2.0-67650215353 10.1161/CIRCRESAHA.109.196667
25. Gustavsson C., Agardh C. D., Zetterqvist A. V., Nilsson J., Agardh E., Gomez M. F., Vascular cellular adhesion molecule-1 (VCAM-1) expression in mice retinal vessels is affected by both hyperglycemia and hyperlipidemia. PloS ONE 2010 5 9 e12699 2-s2.0-79952278418
26. Yoshioka M., Kayo T., Ikeda T., Koizumi A., A novel locus, Mody4, distal to D7Mit189 on chromosome 7 determines early-onset NIDDM in nonobese C57BL/6 (Akita) mutant mice. Diabetes 1997 46 5 887 894 2-s2.0-0030907296 (Pubitemid 27188269)
27. Koseki M., Hirano K. I., Masuda D., Ikegami C., Tanaka M., Ota A., Sandoval J. C., Nakagawa-Toyama Y., Sato S. B., Kobayashi T., Shimada Y., Ohno-Iwashita Y., Matsuura F., Shimomura I., Yamashita S., Increased lipid rafts and accelerated lipopolysaccharide-induced tumor necrosis factor- α secretion in Abca1-deficient macrophages. Journal of Lipid Research 2007 48 2 299 306 2-s2.0-33846883295 10.1194/jlr.M600428-JLR200 (Pubitemid 46220596)
28. Hansson G. K., Libby P., The immune response in atherosclerosis: a double-edged sword. Nature Reviews Immunology 2006 6 7 508 519 2-s2.0-33745571976 10.1038/nri1882 (Pubitemid 43980523)
29. Faulds M. H., Zhao C., Dahlman-Wright K., Gustafsson J., The diversity of sex steroid action: regulation of metabolism by estrogen signaling. Journal of Endocrinology 2012 212 1 3 12 10.1530/JOE-11-0044
30. Reaven P., Merat S., Casanada F., Sutphin M., Palinski W., Effect of streptozotocin-induced hyperglycemia on lipid profiles, formation of advanced glycation endproducts in lesions, and extent of atherosclerosis in LDL receptor-deficient mice. Arteriosclerosis, Thrombosis, and Vascular Biology 1997 17 10 2250 2256 2-s2.0-0031441617 (Pubitemid 28057129)
31. Burcelin R., Crivelli V., Dacosta A., Roy-Tirelli A., Thorens B., Heterogeneous metabolic adaptation of C57BL/6J mice to high-fat diet. American Journal of Physiology 2002 282 4 E834 E842 2-s2.0-0036087662 (Pubitemid 34654745)
32. Garg N., Thakur S., McMahan C. A., Adamo M. L., High fat diet induced insulin resistance and glucose intolerance are gender-specific in IGF-1R heterozygous mice. Biochemical and Biophysical Research Communications 2011 413 3 476 480 10.1016/j.bbrc.2011.08.123
33. Macotela Y., Boucher J., Tran T. T., Kahn C. R., Sex and depot differences in adipocyte insulin sensitivity and glucose. Diabetes 2009 58 4 803 812 2-s2.0-64649104155 10.2337/db08-1054
34. Burke A. P., Kolodgie F. D., Zieske A., Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study. Arteriosclerosis, Thrombosis, and Vascular Biology 2004 24 7 1266 1271 10.1161/01.ATV.0000131783. 74034.97 (Pubitemid 38880019)
35. Venkateswaran A., Laffitte B. A., Joseph S. B., Mak P. A., Wilpitz D. C., Edwards P. A., Tontonoz P., Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR α Proceedings of the National Academy of Sciences of the United States of America 2000 97 22 12097 12102 2-s2.0-0034710965 10.1073/pnas.200367697
36. Tangirala R. K., Bischoff E. D., Joseph S. B., Identification of macrophage liver X receptors as inhibitors of atherosclerosis. Proceedings of the National Academy of Sciences of the United States of America 2002 99 18 11896 11901 10.1073/pnas.182199799 (Pubitemid 34994495)
37. Bradley M. N., Hong C., Chen M., Ligand activation of LXR beta reverses atherosclerosis and cellular cholesterol overload in mice lacking LXR alpha and apoE. Journal of Clinical Investigation 2007 117 8 2337 2346 10.1172/JCI31909 (Pubitemid 47219578)
38. Hong C., Bradley M. N., Rong X., LXRalpha is uniquely required for maximal reverse cholesterol transport and atheroprotection in ApoE-deficient mice. The Journal of Lipid Research 2012 53 6 1126 1133 10.1194/jlr.M022061
39. Dai X. Y., Ou X., Hao X. R., Cao D. L., Tang Y. L., Hu Y. W., Li X. X., Tang C. K., The effect of T0901317 on ATP-binding cassette transporter A1 and niemann-pick type C1 in ApoE-/-mice. Journal of Cardiovascular Pharmacology 2008 51 5 467 475 2-s2.0-55949103021 10.1097/FJC.0b013e31816a5be3
40. Joseph S. B., McKilligin E., Pei L., Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proceedings of the National Academy of Sciences of the United States of America 2002 99 11 7604 7609 10.1073/pnas.112059299 (Pubitemid 34568738)
41. Levin N., Bischoff E. D., Daige C. L., Thomas D., Vu C. T., Heyman R. A., Tangirala R. K., Schulman I. G., Macrophage liver X receptor is required for antiatherogenic activity of LXR agonists. Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 1 135 142 2-s2.0-11144230882 10.1161/01.ATV.0000150044. 84012.68 (Pubitemid 40054266)
42. Verschuren L., de Vries-van der Weij J., Zadelaar S., Kleemann R., Kooistra T., LXR agonist suppresses atherosclerotic lesion growth and promotes lesion regression in apoE*3Leiden mice: time course and mechanisms. Journal of Lipid Research 2009 50 2 301 311 2-s2.0-64749086695 10.1194/jlr.M800374-JLR200
43. Castrillo A., Joseph S. B., Marathe C., Mangelsdorf D. J., Tontonoz P., Liver X receptor-dependent repression of matrix metalloproteinase-9 expression in macrophages. Journal of Biological Chemistry 2003 278 12 10443 10449 2-s2.0-0038193542 10.1074/jbc.M213071200 (Pubitemid 36800310)
44. Joseph S. B., Castrillo A., Laffitte B. A., Mangelsdorf D. J., Tontonoz P., Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nature Medicine 2003 9 2 213 219 2-s2.0-0037324340 10.1038/nm820 (Pubitemid 36227724)
45. Ogawa D., Stone J. F., Takata Y., Blaschke F., Chu V. H., Towler D. A., Law R. E., Hsueh W. A., Bruemmer D., Liver x receptor agonists inhibit cytokine-induced osteopontin expression in macrophages through interference with activator protein-1 signaling pathways. Circulation Research 2005 96 7 e59 e67 2-s2.0-26944447155
46. Aiello R. J., Brees D., Bourassa P. A., Royer L., Lindsey S., Coskran T., Haghpassand M., Francone O. L., Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages. Arteriosclerosis, Thrombosis, and Vascular Biology 2002 22 4 630 637 2-s2.0-0036120566 10.1161/01.ATV. 0000014804.35824.DA (Pubitemid 34408745)
47. Boudina S., Abel E. D., Diabetic cardiomyopathy revisited. Circulation 2007 115 25 3213 3223 2-s2.0-34347352169 10.1161/CIRCULATIONAHA.106.679597 (Pubitemid 47012236)
48. Poornima I. G., Parikh P., Shannon R. P., Diabetic cardiomyopathy: the search for a unifying hypothesis. Circulation Research 2006 98 5 596 605 2-s2.0-33645280925 10.1161/01.RES.0000207406.94146.c2
49. Basu R., Oudit G. Y., Wang X., Zhang L., Ussher J. R., Lopaschuk G. D., Kassiri Z., Type 1 diabetic cardiomyopathy in the Akita (Ins2 WT/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function. American Journal of Physiology 2009 297 6 H2096 H2108 2-s2.0-72249100585 10.1152/ajpheart.00452.2009
50. Gurley S. B., Clare S. E., Snow K. P., Hu A., Meyer T. W., Coffman T. M., Impact of genetic background on nephropathy in diabetic mice. American Journal of Physiology 2006 290 1 F214 F222 2-s2.0-33644802764 10.1152/ajprenal.00204. 2005
51. +/C96Y(Akita) mice. American Journal of Physiology 2010 298 3 F788 F795 2-s2.0-77649123373 10.1152/ajprenal.90515.2008
52. Lo C. S., Liu F., Shi Y., Maachi H., Dual RAS blockade normalizes angiotensin-converting enzyme-2 expression and prevents hypertension and tubular apoptosis in Akita angiotensinogen-transgenic mice. American Journal of Physiology 2012 302 7 F840 F852 10.1152/ajprenal.00340.2011
53. Lu H., Cassis L. A., Daugherty A., Atherosclerosis and arterial blood pressure in mice. Current Drug Targets 2007 8 11 1181 1189 2-s2.0-36949021334 10.2174/138945007782403829 (Pubitemid 350238919)
54. Gotsman I., Gupta R., Lichtman A. H., The influence of the regulatory T lymphocytes on atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 12 2493 2495 2-s2.0-36348991411 10.1161/ATVBAHA.107.153064 (Pubitemid 350158897)